nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Betamethasone—psoriatic arthritis	0.534	0.632	CbGbCtD
Carbimazole—CYP19A1—Dexamethasone—psoriatic arthritis	0.311	0.368	CbGbCtD
Carbimazole—Aplastic anaemia—Auranofin—psoriatic arthritis	0.0056	0.036	CcSEcCtD
Carbimazole—Eosinophilia—Auranofin—psoriatic arthritis	0.0037	0.0238	CcSEcCtD
Carbimazole—Pancytopenia—Auranofin—psoriatic arthritis	0.00355	0.0229	CcSEcCtD
Carbimazole—Neutropenia—Auranofin—psoriatic arthritis	0.0035	0.0225	CcSEcCtD
Carbimazole—Stomatitis—Auranofin—psoriatic arthritis	0.00325	0.0209	CcSEcCtD
Carbimazole—Jaundice—Auranofin—psoriatic arthritis	0.00325	0.0209	CcSEcCtD
Carbimazole—Agranulocytosis—Auranofin—psoriatic arthritis	0.00311	0.02	CcSEcCtD
Carbimazole—Myopathy—Prednisolone—psoriatic arthritis	0.00271	0.0174	CcSEcCtD
Carbimazole—Alopecia—Auranofin—psoriatic arthritis	0.00265	0.017	CcSEcCtD
Carbimazole—Myopathy—Triamcinolone—psoriatic arthritis	0.00249	0.016	CcSEcCtD
Carbimazole—Myopathy—Methylprednisolone—psoriatic arthritis	0.00249	0.016	CcSEcCtD
Carbimazole—Throat sore—Triamcinolone—psoriatic arthritis	0.00243	0.0156	CcSEcCtD
Carbimazole—Oropharyngeal discomfort—Triamcinolone—psoriatic arthritis	0.0024	0.0155	CcSEcCtD
Carbimazole—Angioedema—Auranofin—psoriatic arthritis	0.00238	0.0153	CcSEcCtD
Carbimazole—Leukopenia—Auranofin—psoriatic arthritis	0.00233	0.015	CcSEcCtD
Carbimazole—Myopathy—Dexamethasone—psoriatic arthritis	0.00226	0.0146	CcSEcCtD
Carbimazole—Myopathy—Betamethasone—psoriatic arthritis	0.00226	0.0146	CcSEcCtD
Carbimazole—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00208	0.0134	CcSEcCtD
Carbimazole—Myopathy—Prednisone—psoriatic arthritis	0.00197	0.0127	CcSEcCtD
Carbimazole—Oropharyngeal pain—Triamcinolone—psoriatic arthritis	0.00192	0.0124	CcSEcCtD
Carbimazole—Contusion—Dexamethasone—psoriatic arthritis	0.00182	0.0117	CcSEcCtD
Carbimazole—Contusion—Betamethasone—psoriatic arthritis	0.00182	0.0117	CcSEcCtD
Carbimazole—Bone marrow depression—Methotrexate—psoriatic arthritis	0.00171	0.011	CcSEcCtD
Carbimazole—Liver disorder—Methotrexate—psoriatic arthritis	0.00169	0.0109	CcSEcCtD
Carbimazole—Urticaria—Auranofin—psoriatic arthritis	0.00169	0.0109	CcSEcCtD
Carbimazole—Contusion—Prednisone—psoriatic arthritis	0.00158	0.0102	CcSEcCtD
Carbimazole—Pruritus—Auranofin—psoriatic arthritis	0.0015	0.00968	CcSEcCtD
Carbimazole—Rash—Auranofin—psoriatic arthritis	0.00134	0.00863	CcSEcCtD
Carbimazole—Dermatitis—Auranofin—psoriatic arthritis	0.00134	0.00862	CcSEcCtD
Carbimazole—Nausea—Auranofin—psoriatic arthritis	0.00126	0.00813	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00108	0.00697	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—psoriatic arthritis	0.00104	0.00672	CcSEcCtD
Carbimazole—Haemoglobin—Prednisolone—psoriatic arthritis	0.000959	0.00617	CcSEcCtD
Carbimazole—Haemorrhage—Prednisolone—psoriatic arthritis	0.000955	0.00614	CcSEcCtD
Carbimazole—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000882	0.00568	CcSEcCtD
Carbimazole—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00088	0.00566	CcSEcCtD
Carbimazole—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000878	0.00565	CcSEcCtD
Carbimazole—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000876	0.00564	CcSEcCtD
Carbimazole—Neutropenia—Prednisone—psoriatic arthritis	0.00081	0.00521	CcSEcCtD
Carbimazole—Haemoglobin—Betamethasone—psoriatic arthritis	0.000801	0.00515	CcSEcCtD
Carbimazole—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000801	0.00515	CcSEcCtD
Carbimazole—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000797	0.00513	CcSEcCtD
Carbimazole—Haemorrhage—Betamethasone—psoriatic arthritis	0.000797	0.00513	CcSEcCtD
Carbimazole—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000795	0.00511	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000774	0.00498	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000771	0.00496	CcSEcCtD
Carbimazole—Angioedema—Prednisolone—psoriatic arthritis	0.000759	0.00489	CcSEcCtD
Carbimazole—Malaise—Prednisolone—psoriatic arthritis	0.000749	0.00482	CcSEcCtD
Carbimazole—Angiopathy—Dexamethasone—psoriatic arthritis	0.000723	0.00465	CcSEcCtD
Carbimazole—Angiopathy—Betamethasone—psoriatic arthritis	0.000723	0.00465	CcSEcCtD
Carbimazole—Eosinophilia—Methotrexate—psoriatic arthritis	0.000717	0.00461	CcSEcCtD
Carbimazole—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000709	0.00456	CcSEcCtD
Carbimazole—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000707	0.00455	CcSEcCtD
Carbimazole—Alopecia—Dexamethasone—psoriatic arthritis	0.000704	0.00453	CcSEcCtD
Carbimazole—Alopecia—Betamethasone—psoriatic arthritis	0.000704	0.00453	CcSEcCtD
Carbimazole—Discomfort—Prednisolone—psoriatic arthritis	0.000699	0.0045	CcSEcCtD
Carbimazole—Angioedema—Triamcinolone—psoriatic arthritis	0.000698	0.00449	CcSEcCtD
Carbimazole—Haemoglobin—Prednisone—psoriatic arthritis	0.000697	0.00449	CcSEcCtD
Carbimazole—Angioedema—Methylprednisolone—psoriatic arthritis	0.000697	0.00448	CcSEcCtD
Carbimazole—Haemorrhage—Prednisone—psoriatic arthritis	0.000694	0.00446	CcSEcCtD
Carbimazole—Malaise—Triamcinolone—psoriatic arthritis	0.000689	0.00443	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—psoriatic arthritis	0.000688	0.00443	CcSEcCtD
Carbimazole—Malaise—Methylprednisolone—psoriatic arthritis	0.000688	0.00442	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—psoriatic arthritis	0.000677	0.00436	CcSEcCtD
Carbimazole—Myalgia—Triamcinolone—psoriatic arthritis	0.000651	0.00419	CcSEcCtD
Carbimazole—Myalgia—Methylprednisolone—psoriatic arthritis	0.000649	0.00418	CcSEcCtD
Carbimazole—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000649	0.00418	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000645	0.00415	CcSEcCtD
Carbimazole—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000643	0.00414	CcSEcCtD
Carbimazole—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000643	0.00414	CcSEcCtD
Carbimazole—Discomfort—Triamcinolone—psoriatic arthritis	0.000643	0.00414	CcSEcCtD
Carbimazole—Discomfort—Methylprednisolone—psoriatic arthritis	0.000641	0.00413	CcSEcCtD
Carbimazole—Angioedema—Dexamethasone—psoriatic arthritis	0.000634	0.00408	CcSEcCtD
Carbimazole—Angioedema—Betamethasone—psoriatic arthritis	0.000634	0.00408	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—psoriatic arthritis	0.00063	0.00405	CcSEcCtD
Carbimazole—Angiopathy—Prednisone—psoriatic arthritis	0.000629	0.00405	CcSEcCtD
Carbimazole—Malaise—Betamethasone—psoriatic arthritis	0.000625	0.00402	CcSEcCtD
Carbimazole—Malaise—Dexamethasone—psoriatic arthritis	0.000625	0.00402	CcSEcCtD
Carbimazole—Infection—Triamcinolone—psoriatic arthritis	0.00062	0.00399	CcSEcCtD
Carbimazole—Infection—Methylprednisolone—psoriatic arthritis	0.000618	0.00398	CcSEcCtD
Carbimazole—Alopecia—Prednisone—psoriatic arthritis	0.000613	0.00394	CcSEcCtD
Carbimazole—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00061	0.00393	CcSEcCtD
Carbimazole—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000604	0.00389	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000603	0.00388	CcSEcCtD
Carbimazole—Myalgia—Betamethasone—psoriatic arthritis	0.00059	0.0038	CcSEcCtD
Carbimazole—Myalgia—Dexamethasone—psoriatic arthritis	0.00059	0.0038	CcSEcCtD
Carbimazole—Discomfort—Betamethasone—psoriatic arthritis	0.000583	0.00375	CcSEcCtD
Carbimazole—Discomfort—Dexamethasone—psoriatic arthritis	0.000583	0.00375	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—psoriatic arthritis	0.000583	0.00375	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—psoriatic arthritis	0.00058	0.00373	CcSEcCtD
Carbimazole—Hepatitis—Methotrexate—psoriatic arthritis	0.00058	0.00373	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000568	0.00366	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000567	0.00365	CcSEcCtD
Carbimazole—Infection—Dexamethasone—psoriatic arthritis	0.000562	0.00362	CcSEcCtD
Carbimazole—Infection—Betamethasone—psoriatic arthritis	0.000562	0.00362	CcSEcCtD
Carbimazole—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00056	0.00361	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000559	0.0036	CcSEcCtD
Carbimazole—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000555	0.00357	CcSEcCtD
Carbimazole—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000555	0.00357	CcSEcCtD
Carbimazole—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000554	0.00357	CcSEcCtD
Carbimazole—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000554	0.00357	CcSEcCtD
Carbimazole—Angioedema—Prednisone—psoriatic arthritis	0.000552	0.00355	CcSEcCtD
Carbimazole—Malaise—Prednisone—psoriatic arthritis	0.000545	0.0035	CcSEcCtD
Carbimazole—Urticaria—Prednisolone—psoriatic arthritis	0.000539	0.00347	CcSEcCtD
Carbimazole—Angiopathy—Methotrexate—psoriatic arthritis	0.000526	0.00338	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000516	0.00332	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000516	0.00332	CcSEcCtD
Carbimazole—Myalgia—Prednisone—psoriatic arthritis	0.000514	0.00331	CcSEcCtD
Carbimazole—Arthralgia—Prednisone—psoriatic arthritis	0.000514	0.00331	CcSEcCtD
Carbimazole—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000514	0.00331	CcSEcCtD
Carbimazole—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000513	0.0033	CcSEcCtD
Carbimazole—Alopecia—Methotrexate—psoriatic arthritis	0.000512	0.0033	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000511	0.00329	CcSEcCtD
Carbimazole—Discomfort—Prednisone—psoriatic arthritis	0.000508	0.00327	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0005	0.00322	CcSEcCtD
Carbimazole—Urticaria—Triamcinolone—psoriatic arthritis	0.000495	0.00319	CcSEcCtD
Carbimazole—Urticaria—Methylprednisolone—psoriatic arthritis	0.000494	0.00318	CcSEcCtD
Carbimazole—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000493	0.00317	CcSEcCtD
Carbimazole—Infection—Prednisone—psoriatic arthritis	0.00049	0.00315	CcSEcCtD
Carbimazole—Nervous system disorder—Prednisone—psoriatic arthritis	0.000483	0.00311	CcSEcCtD
Carbimazole—Skin disorder—Prednisone—psoriatic arthritis	0.000479	0.00308	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000468	0.00301	CcSEcCtD
Carbimazole—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000466	0.003	CcSEcCtD
Carbimazole—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000466	0.003	CcSEcCtD
Carbimazole—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00046	0.00296	CcSEcCtD
Carbimazole—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000459	0.00295	CcSEcCtD
Carbimazole—Malaise—Methotrexate—psoriatic arthritis	0.000455	0.00293	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—psoriatic arthritis	0.000452	0.00291	CcSEcCtD
Carbimazole—Urticaria—Betamethasone—psoriatic arthritis	0.00045	0.00289	CcSEcCtD
Carbimazole—Urticaria—Dexamethasone—psoriatic arthritis	0.00045	0.00289	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000449	0.00289	CcSEcCtD
Carbimazole—Body temperature increased—Betamethasone—psoriatic arthritis	0.000447	0.00288	CcSEcCtD
Carbimazole—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000447	0.00288	CcSEcCtD
Carbimazole—Pruritus—Triamcinolone—psoriatic arthritis	0.000441	0.00284	CcSEcCtD
Carbimazole—Pruritus—Methylprednisolone—psoriatic arthritis	0.00044	0.00283	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—psoriatic arthritis	0.00043	0.00276	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—psoriatic arthritis	0.00043	0.00276	CcSEcCtD
Carbimazole—Rash—Prednisolone—psoriatic arthritis	0.000428	0.00275	CcSEcCtD
Carbimazole—Dermatitis—Prednisolone—psoriatic arthritis	0.000427	0.00275	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000427	0.00275	CcSEcCtD
Carbimazole—Headache—Prednisolone—psoriatic arthritis	0.000425	0.00273	CcSEcCtD
Carbimazole—Discomfort—Methotrexate—psoriatic arthritis	0.000425	0.00273	CcSEcCtD
Carbimazole—Infection—Methotrexate—psoriatic arthritis	0.000409	0.00263	CcSEcCtD
Carbimazole—Feeling abnormal—Prednisone—psoriatic arthritis	0.000406	0.00261	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000404	0.0026	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000403	0.00259	CcSEcCtD
Carbimazole—Nausea—Prednisolone—psoriatic arthritis	0.000403	0.00259	CcSEcCtD
Carbimazole—Pruritus—Dexamethasone—psoriatic arthritis	0.0004	0.00258	CcSEcCtD
Carbimazole—Pruritus—Betamethasone—psoriatic arthritis	0.0004	0.00258	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—psoriatic arthritis	0.0004	0.00257	CcSEcCtD
Carbimazole—Rash—Triamcinolone—psoriatic arthritis	0.000393	0.00253	CcSEcCtD
Carbimazole—Dermatitis—Triamcinolone—psoriatic arthritis	0.000393	0.00253	CcSEcCtD
Carbimazole—Rash—Methylprednisolone—psoriatic arthritis	0.000392	0.00252	CcSEcCtD
Carbimazole—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000392	0.00252	CcSEcCtD
Carbimazole—Urticaria—Prednisone—psoriatic arthritis	0.000392	0.00252	CcSEcCtD
Carbimazole—Headache—Triamcinolone—psoriatic arthritis	0.000391	0.00251	CcSEcCtD
Carbimazole—Headache—Methylprednisolone—psoriatic arthritis	0.00039	0.00251	CcSEcCtD
Carbimazole—Body temperature increased—Prednisone—psoriatic arthritis	0.00039	0.00251	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000375	0.00241	CcSEcCtD
Carbimazole—Nausea—Triamcinolone—psoriatic arthritis	0.00037	0.00238	CcSEcCtD
Carbimazole—Nausea—Methylprednisolone—psoriatic arthritis	0.00037	0.00238	CcSEcCtD
Carbimazole—Hypersensitivity—Prednisone—psoriatic arthritis	0.000363	0.00234	CcSEcCtD
Carbimazole—Rash—Betamethasone—psoriatic arthritis	0.000357	0.0023	CcSEcCtD
Carbimazole—Rash—Dexamethasone—psoriatic arthritis	0.000357	0.0023	CcSEcCtD
Carbimazole—Dermatitis—Betamethasone—psoriatic arthritis	0.000356	0.00229	CcSEcCtD
Carbimazole—Dermatitis—Dexamethasone—psoriatic arthritis	0.000356	0.00229	CcSEcCtD
Carbimazole—Headache—Dexamethasone—psoriatic arthritis	0.000355	0.00228	CcSEcCtD
Carbimazole—Headache—Betamethasone—psoriatic arthritis	0.000355	0.00228	CcSEcCtD
Carbimazole—Pruritus—Prednisone—psoriatic arthritis	0.000349	0.00224	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000339	0.00218	CcSEcCtD
Carbimazole—Nausea—Dexamethasone—psoriatic arthritis	0.000336	0.00216	CcSEcCtD
Carbimazole—Nausea—Betamethasone—psoriatic arthritis	0.000336	0.00216	CcSEcCtD
Carbimazole—Urticaria—Methotrexate—psoriatic arthritis	0.000327	0.00211	CcSEcCtD
Carbimazole—Body temperature increased—Methotrexate—psoriatic arthritis	0.000326	0.0021	CcSEcCtD
Carbimazole—Rash—Prednisone—psoriatic arthritis	0.000311	0.002	CcSEcCtD
Carbimazole—Dermatitis—Prednisone—psoriatic arthritis	0.00031	0.002	CcSEcCtD
Carbimazole—Headache—Prednisone—psoriatic arthritis	0.000309	0.00199	CcSEcCtD
Carbimazole—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000303	0.00195	CcSEcCtD
Carbimazole—Nausea—Prednisone—psoriatic arthritis	0.000293	0.00188	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—psoriatic arthritis	0.000291	0.00188	CcSEcCtD
Carbimazole—Rash—Methotrexate—psoriatic arthritis	0.00026	0.00167	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—psoriatic arthritis	0.000259	0.00167	CcSEcCtD
Carbimazole—Headache—Methotrexate—psoriatic arthritis	0.000258	0.00166	CcSEcCtD
Carbimazole—Nausea—Methotrexate—psoriatic arthritis	0.000245	0.00157	CcSEcCtD
